Libcice nad Vltavou, Czechia

Marketa Slavikova

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Zentiva K.s.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marketa Slavikova. Retrieved from https://idiyas.com/inventor/marketa-slavikova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marketa Slavikova: Innovator in Pharmaceutical Chemistry

Introduction

Marketa Slavikova is a notable inventor based in Libcice nad Vltavou, Czech Republic. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of specific compounds used in medication.

Latest Patents

Marketa holds a patent for a method of preparation of (R)-(−)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide. This innovative method involves introducing a protective group to N-[(1R)-2(4-methoxyphenyl)-1-methylethyl]-N-[(1R)-1-phenylethyl)]amine. The resulting amide is chlorosulfonated, and the sulfochloride is converted to a sulfonamide, ultimately yielding the compound used in the production of tamsulosin. She has 1 patent to her name.

Career Highlights

Marketa is currently employed at Zentiva a.s., where she continues to advance her research and development efforts in the pharmaceutical industry. Her work focuses on innovative methods that enhance the efficacy and production of essential medications.

Collaborations

Marketa collaborates with her coworker, Josef Hajicek, to further explore advancements in their field. Their combined expertise contributes to the innovative environment at Zentiva.

Conclusion

Marketa Slavikova is a pioneering inventor whose work in pharmaceutical chemistry has the potential to impact the production of vital medications. Her dedication to innovation and collaboration exemplifies the spirit of advancement in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…